Clinical trial
Prospective, MulticEnter, Randomized, International Study of the SING IMT™ Prosthesis in Pseudophakic patiEnts With Stable Moderate to Profound Bilateral Central vIsion Impairment Due to adVancEd AMD / PERSPECTIVE Study
NCT07164378 is registered in ClinicalTrials.gov with VisionCare, Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Prospective, MulticEnter, Randomized, International Study of the SING IMT™ Prosthesis in Pseudophakic patiEnts With Stable Moderate to Profound Bilateral Central vIsion Impairment Due to adVancEd AMD / PERSPECTIVE Study
- Lead sponsor
- VisionCare, Inc.
- Phase
- Not applicable
- Overall status
- Recruiting
- Start date
- September 23, 2025
- Completion date
- April 30, 2027
- Enrollment
- 44 (estimated)
- Sites
- 12
Conditions
As the registry lists them; a condition with its own page is linked.
age - related macular degeneration (amd)